Status:

COMPLETED

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Lead Sponsor:

Sumitomo Pharma America, Inc.

Conditions:

Schizophrenia

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared wi...

Eligibility Criteria

Inclusion

  • Provide written informed consent and aged between 18 and 75 years of age.
  • Meets DSM-IV™ criteria for a primary diagnosis of schizophrenia.
  • Not pregnant, if of reproductive potential agrees to remain abstinent or use adequate and reliable contraception for duration of study.
  • Able and agrees to remain off prior antipsychotic medication for the duration of study.
  • Good physical health on the basis of medical history, physical examination, and laboratory screening.
  • Willing and able to comply with the protocol, including the inpatient requirements and outpatient visits.

Exclusion

  • Considered by the investigator to be at imminent risk of suicide or injury to self, others, or property.
  • Any chronic organic disease of the CNS (other than schizophrenia).
  • Used investigational compound within 30 days.
  • Clinically significant or history of alcohol abuse/alcoholism or drug abuse/dependence within the last 6 months.

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

488 Patients enrolled

Trial Details

Trial ID

NCT00790192

Start Date

October 1 2008

End Date

July 1 2010

Last Update

March 17 2016

Active Locations (65)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (65 locations)

1

K&S Professional Research Services, LLC

Little Rock, Arkansas, United States, 72201

2

Woodland International Research Group

Little Rock, Arkansas, United States, 72211

3

Clinical Pharmacological Studies, Inc.

Cerritos, California, United States, 90703

4

Comprehensive Neuroscience, Inc

Cerritos, California, United States, 90703